|
|
||||||||
The Journal of Immunology, Vol 154, Issue 6 2724-2732, Copyright © 1995 by American Association of Immunologists
ARTICLES |
V Romano-Spica, P Georgiou, H Suzuki, TS Papas and NK Bhat
Laboratory of Molecular Oncology, National Cancer Institute, Frederick, MD 21702.
The ETS1 gene encodes a sequence-specific transcription factor binding to purine-rich DNA sequences (-GGAA-) present in the transcriptional regulatory regions of many cellular and viral promoters/enhancers, including many lymphokine genes. The ETS1 gene is expressed at high levels in resting T cells and at very low levels after T cell activation, suggesting it may suppress the expression of genes induced during T cell activation. To find out if ETS1 regulates expression of the IL-2 gene, we have ectopically expressed antisense (AS) ETS1 in Jurkat T cells to block the formation of ETS1 proteins. AS ETS1 transfectants produce higher levels of IL-2 compared with sense ETS1 transfectants. Expression of ETS1 DNA binding domain in Jurkat T cells also decreased the production of IL-2. In AS ETS1 transfectants, IL-2 formation was completely inhibited by cyclosporin A and FK590. The IL-2 promoter linked to a chloramphenicol acetyl transferase reporter gene has high activity in AS ETS1 transfectants, indicating that increased IL-2 production seems to be a result of transcriptional induction. Taken together, these results suggest the possibility that ETS1 may act as a negative regulator of IL-2 gene transcription and provide a rational approach toward engineering the endogenous expression of IL-2 in T cells.
This article has been cited by other articles:
![]() |
Y.-T. Juang, L. Sumibcay, M. Tolnay, Y. Wang, V. C. Kyttaris, and G. C. Tsokos Elf-1 Binds to GGAA Elements on the FcR{gamma} Promoter and Represses Its Expression J. Immunol., October 1, 2007; 179(7): 4884 - 4889. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Grenningloh, B. Y. Kang, and I-C. Ho Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses J. Exp. Med., February 22, 2005; 201(4): 615 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cianferoni, J. T. Schroeder, J. Kim, J. W. Schmidt, L. M. Lichtenstein, S. N. Georas, and V. Casolaro Selective inhibition of interleukin-4 gene expression in human T cells by aspirin Blood, March 15, 2001; 97(6): 1742 - 1749. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Vallejo, A. R. Nestel, M. Schirmer, C. M. Weyand, and J. J. Goronzy Aging-related Deficiency of CD28 Expression in CD4+ T Cells Is Associated with the Loss of Gene-specific Nuclear Factor Binding Activity J. Biol. Chem., April 3, 1998; 273(14): 8119 - 8129. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Rellahan, J. P. Jensen, T. K. Howcroft, D. S. Singer, E. Bonvini, and A. M. Weissman Elf-1 Regulates Basal Expression from the T Cell Antigen Receptor {zeta}-Chain Gene Promoter J. Immunol., March 15, 1998; 160(6): 2794 - 2801. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grigoryev, A. E. Stewart, Y. T. Kwon, S. M. Arfin, R. A. Bradshaw, N. A. Jenkins, N. G. Copeland, and A. Varshavsky A Mouse Amidase Specific for N-terminal Asparagine. THE GENE, THE ENZYME, AND THEIR FUNCTION IN THE N-END RULE PATHWAY J. Biol. Chem., November 8, 1996; 271(45): 28521 - 28532. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Nirodi, J. Hart, P. Dhawan, N.-s. Moon, A. Nepveu, and A. Richmond The Role of CDP in the Negative Regulation of CXCL1 Gene Expression J. Biol. Chem., July 6, 2001; 276(28): 26122 - 26131. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |